Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 May 13;16(5):102506. doi: 10.1016/j.dsx.2022.102506

Erratum regarding missing Declaration of Competing Interest statements in previously published articles

PMCID: PMC9098958  PMID: 35570171

Declaration of Competing Interest statements were not included in published version of the following articles that appeared in previous issues of Diabetes & Metabolic Syndrome: Clinical Research & Reviews. Hence, the authors of the below articles were contacted after publication to request a Declaration of Interest statement:

  • 1.

    “The impact of structured diabetes education on glycemic control during Ramadan fasting in diabetic patients in Beni Suef, Egypt” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (5)] https://doi.org/10.1016/j.dsx.2021.102249

  • 2.

    “Heterogeneity in Presentation of hyperglycaemia during COVID-19 pandemic: A Proposed Classification” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (1): 403–406] https://doi.org/10.1016/j.dsx.2021.01.018

  • 3.

    “Role of oxidized LDL-induced “trained macrophages” in the pathogenesis of COVID-19 and benefits of pioglitazone: A hypothesis” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (4): 713–714] https://doi.org/10.1016/j.dsx.2020.05.007

  • 4.

    “Post COVID Syndrome (“Long COVID”) and Diabetes: Challenges in Diagnosis and Management” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (5)] https://doi.org/10.1016/j.dsx.2021.102235

  • 5.

    “Evaluation of simple and cost-effective immuno-haematological markers to predict outcome in hospitalized severe COVID-19 patients, with a focus on diabetes mellitus - A retrospective study in Andhra Pradesh, India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 739–475] https://doi.org/10.1016/j.dsx.2021.03.025

  • 6.

    “Use of insulin glargine during pregnancy: A review” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (1): 379–384] https://doi.org/10.1016/j.dsx.2021.01.012

  • 7.

    “Profile of diabetic ketoacidosis at the National Diabetes and Endocrine Center in Tripoli, Libya, 2015” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 771–775] https://doi.org/10.1016/j.dsx.2021.03.014

  • 8.

    “Professor Jitendra Nath Pande: Obituaries” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 981–982] https://doi.org/10.1016/j.dsx.2020.06.002

  • 9.

    “Brazilian Portuguese version of the Mediterranean diet scale: Translation procedures and measurement properties” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (4)] https://doi.org/10.1016/j.dsx.2021.06.002

  • 10.

    “The relationship between fasting plasma glucose in the first trimester of pregnancy and the incidence of gestational diabetes in Iran” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (4)] https://doi.org/10.1016/j.dsx.2021.102193

  • 11.

    “Is newly diagnosed diabetes as frequent as preexisting diabetes in COVID-19 patients?” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 15 (1): 147–148] https://doi.org/10.1016/j.dsx.2020.12.024

  • 12.

    “Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14 (5): 809–814] https://doi.org/10.1016/j.dsx.2020.06.016

  • 13.

    “Body composition and handgrip strength in patients with prediabetes: A case-control study from Haryana, North India” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 823–827] https://doi.org/10.1016/j.dsx.2021.03.036

  • 14.

    “Lower versus standard sucrose dose for treating hypoglycemia in patients with type 1 diabetes mellitus in therapy with predictive low glucose suspend (PLGS) augmented insulin pumps: A randomized crossover trial in Santiago, Chile” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (3): 695–701] https://doi.org/10.1016/j.dsx.2021.03.017

  • 15.

    “Steroid use during Covid-19 infection and Hyperglycemia – What a Physician should know” [Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021; 15 (4)] https://doi.org/10.1016/j.dsx.2021.06.004


Articles from Diabetes & Metabolic Syndrome are provided here courtesy of Elsevier

RESOURCES